Follow the 엑셀세라퓨틱스 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 엑셀세라퓨틱스 has logged 4 insider filings. Market capitalisation: €18.7bn. The latest transaction was disclosed on 1 April 2026 (Sale). Among the most active insiders: 이의일. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Excel Therapeutics is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative therapies.